HOTH News and Press, Hoth Therapeutics Inc. From 07/12/22

The nano-cap biopharma Hoth Therapeutics ( NASDAQ: HOTH ) jumped ~39% in the morning hours Tuesday after the company announced proof-of-concept data supporting its Alzheimer’s candidate HT-ALZ based on a mouse model. The chronic oral dosing of HT-ALZ over more t...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer's Disease Mouse Model PR Newswire Chronic treatment with HT-ALZ (>5 weeks) demonstrated significant improvement in behavioral and cognitive function tests in an Alzheimer's dise...

Nasdaq has granted Hoth Therapeutics ( NASDAQ: HOTH ) an additional 180-days or until December 26, 2022 to regain compliance with minimum $1.00 closing bid price per share requirement. In a letter dated December 30, 2021, the co...

Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule PR Newswire NEW YORK , June 29, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("Hoth" or the "Company") today announced that the Company received ...

3 Tips for Buying Penny Stocks in July If you’re thinking about buying penny stocks in 2022, there is a lot to know. As traders, it is our job to find the best penny stocks to buy and study them. We need to understand current trends, global market conditions that may effect t...

Hoth Therapeutics Announces HREC Approval in Australia for the Next Phase of its Trial of BioLexa for Patients with Atopic Dermatitis PR Newswire NEW YORK , June 21, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopha...

Hoth Announces Adjournment of Annual Meeting of Shareholders Until June 23, 2022 PR Newswire NEW YORK , June 15, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that its An...

Hoth Therapeutics (NASDAQ:HOTH) on Thursday said it had entered into an extension of its research agreement with the Washington University in St. Louis, Mo. for the continued R&D of Hoth's HT-ALZ, a therapeutic for the treatment of Alzheimer's disease. HOTH stock -3.9% to $0.42 ...

Hoth Therapeutics Announces Extension of Washington University Alzheimer's Mouse Model Study with Alzheimer's Therapeutic HT-ALZ PR Newswire The focus of the new studies is to determine a human equivalent dose of HT-ALZ for starting human clinical trials NEW ...

Hoth Therapeutics Announces Preliminary Efficacy Findings From Phase 1b Clinical Trial with Mild to Moderate Atopic Dermatitis Patient Cohort PR Newswire The preliminary findings reported include patients that showed improvement in atopic dermatitis symptoms and severi...